Chembio Diagnostics Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Chembio Diagnostics (CEMI) Misses Q3 EPS by 2c
November 10, 2016 8:53 AM ESTChembio Diagnostics (NASDAQ: CEMI) reported Q3 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.75 million versus the consensus estimate of $3.76 million.
For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.
... More